Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases
Heart Podcast
00:00
Exploring the Renal Benefits of Sodium Glucose Cotransporter 2 Inhibitors
Explore the use of SGLT2 inhibitors in chronic kidney disease patients, showcasing the renal protective benefits in studies like Canvas R, M-Pareg, Credence Study, and DAPA-CKD, regardless of diabetes status.
Transcript
Play full episode
